Back to Journals » International Journal of Nanomedicine » Volume 2 » Issue 4

VivaGel™ (SPL7013 Gel): A candidate dendrimer - microbicide for the prevention of HIV and HSV infection

Authors Richard Rupp, Susan L Rosenthal, Lawrence R Stanberry

Published 15 January 2008 Volume 2007:2(4) Pages 561—566

Richard Rupp, Susan L Rosenthal, Lawrence R Stanberry

Sealy Center for Vaccine Development and Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA

Abstract: Microbicides are compounds that applied vaginally or rectally, protect the user from sexually transmitted infections. Although no commercial product is yet available, many candidates are under development. A leading candidate, VivaGel™ (SPL7013 Gel) is the product of nanotechnology. The active ingredient is SPL7013, a dendrimer that was designed specifically with HIV and HSV antiviral activity and human safety in mind. SPL7013 has demonstrated efficacy against human immunodeficiency virus and herpes simplex virus in in vitro and animal models. VivaGel™ appears to be well tolerated in both animals and humans. This review summarizes the studies of VivaGel™ and its active ingredient, SPL7013.
Keywords: microbicide, dendrimer, SPL7013, VivaGel™

Download Article [PDF] 

Readers of this article also read:

Theory of planned behavior and smoking: meta-analysis and SEM model

Gabriela Topa, Juan Antonio Moriano

Substance Abuse and Rehabilitation 2010, 1:23-33

Published Date: 6 December 2010

The spectrum of use of rituximab in chronic lymphocytic leukemia

Alessandra Tedeschi, Eleonora Vismara, Francesca Ricci, et al

OncoTargets and Therapy 2010, 3:227-246

Published Date: 26 November 2010

Efficacy and safety of tiotropium Respimat® SMI in COPD in two 1-year randomized studies

Eric Bateman, Dave Singh, David Smith, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:197-208

Published Date: 9 June 2010

Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002

Estelle Lavie, Mélina Fatséas, Jean-Pierre Daulouède, Cécile Denis, Jacques Dubernet, et al

Patient Preference and Adherence 2008, 2:369-378

Published Date: 27 November 2008

Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis

Li-Tao Cheng, Li-Jun Tang, Hui-Min Chen, Wen Tang, Tao Wang

Vascular Health and Risk Management 2008, 4:871-876

Published Date: 8 August 2008

Exosome nanovesicles displaying G protein-coupled receptors for drug discovery

Angeles Estelles, Jeff Sperinde, Thibaut Roulon, Barbara Aguilar, Caroline Bonner

International Journal of Nanomedicine 2007, 2:751-760

Published Date: 15 January 2008

Review of bosentan in the management of pulmonary arterial hypertension

Eli Gabbay, John Fraser, Keith McNeil

Vascular Health and Risk Management 2007, 3:887-900

Published Date: 15 January 2008

Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes

Massimo Bottini, Federica D’Annibale, Andrea Magrini, Fabio Cerignoli, Yutaka Arimura, Marcia I Dawson, Enrico Bergamaschi, Nicola Rosato, Antonio Bergamaschi, Tomas Mustelin

International Journal of Nanomedicine 2007, 2:227-233

Published Date: 15 July 2007

Characterization of electrospun nanocomposite scaffolds and biocompatibility with adipose-derived human mesenchymal stem cells

Seth D McCullen, Derrick R Stevens, Wesley A Roberts, Laura I Clarke, Susan H Bernacki,
Russell E Gorga, Elizabeth G Loboa

International Journal of Nanomedicine 2007, 2:253-263

Published Date: 15 July 2007